Karin Rådholm1, Hisatomi Arima2, Richard I Lindley2, Jiguang Wang3, Christophe Tzourio4, Thompson Robinson5, Emma Heeley2, Craig S Anderson2, John Chalmers2. 1. Division of Community Medicine, Primary Care, Department of Medicine and Health Sciences, Faculty of Health Sciences, Department of Local Care West, Linköping University, County Council of Östergötland, Linköping, Sweden. 2. The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, NSW, Australia. 3. The Shanghai Institute of Hypertension, Rui Jin Hospital, Shanghai Jiaotong University, Shanghai, China. 4. INSERM U897, Bordeaux, France University of Bordeaux, Bordeaux, France. 5. The Department of Cardiovascular Sciences and NIHR Biomedical Research Unit in Cardiovascular Disease, University of Leicester, Leicester, UK.
Abstract
BACKGROUND AND PURPOSE: Global ageing contributes greatly to the burden of stroke. We investigated the influence of age on the baseline profile and on outcomes in acute intracerebral haemorrhage (ICH) among participants of the INTERACT2 study. METHODS: INTERACT2 was an international, randomised controlled trial in 2839 patients with spontaneous ICH within 6 h of onset and elevated systolic blood pressure (SBP; 150-220 mmHg) who were allocated to receive intensive (target SBP <140 mmHg within 1 h) or guideline-recommended (target SBP <180 mmHg) blood pressure lowering treatment. Stroke severity was assessed with the National Institutes of Health Stroke Scale. Poor outcome was defined as death or major disability ('dependency', modified Rankin Scale scores 3-6) at 90 days. Health-related quality of life (HRQoL) was assessed with the European Quality of Life-5 Dimensions (EQ-5D) questionnaire. Associations between age and outcomes were analysed in multivariable logistic regression models. RESULTS:Stroke severity increased in categories of older age (P-trend 0.002). Stroke patients over 75 years old were four times more likely to die or be disabled at 90 days than those <52 years when other confounders were accounted for (odds ratio 4.36, 95% confidence interval 3.12-6.08). Older age was also associated with decreasing HRQoL, across mobility, self-care, usual activities and depression (all P-trend <0.001), and pain or discomfort (P-trend 0.022). CONCLUSION: In the INTERACT2 cohort, older people had more severe ICH and worse outcomes (death, major disability and HRQoL). These data will help guide clinicians manage older people with haemorrhagic stroke. CLINICAL TRIAL REGISTRATION: http://www.clinicaltrials.gov (NCT00716079).
RCT Entities:
BACKGROUND AND PURPOSE: Global ageing contributes greatly to the burden of stroke. We investigated the influence of age on the baseline profile and on outcomes in acute intracerebral haemorrhage (ICH) among participants of the INTERACT2 study. METHODS: INTERACT2 was an international, randomised controlled trial in 2839 patients with spontaneous ICH within 6 h of onset and elevated systolic blood pressure (SBP; 150-220 mmHg) who were allocated to receive intensive (target SBP <140 mmHg within 1 h) or guideline-recommended (target SBP <180 mmHg) blood pressure lowering treatment. Stroke severity was assessed with the National Institutes of Health Stroke Scale. Poor outcome was defined as death or major disability ('dependency', modified Rankin Scale scores 3-6) at 90 days. Health-related quality of life (HRQoL) was assessed with the European Quality of Life-5 Dimensions (EQ-5D) questionnaire. Associations between age and outcomes were analysed in multivariable logistic regression models. RESULTS:Stroke severity increased in categories of older age (P-trend 0.002). Strokepatients over 75 years old were four times more likely to die or be disabled at 90 days than those <52 years when other confounders were accounted for (odds ratio 4.36, 95% confidence interval 3.12-6.08). Older age was also associated with decreasing HRQoL, across mobility, self-care, usual activities and depression (all P-trend <0.001), and pain or discomfort (P-trend 0.022). CONCLUSION: In the INTERACT2 cohort, older people had more severe ICH and worse outcomes (death, major disability and HRQoL). These data will help guide clinicians manage older people with haemorrhagic stroke. CLINICAL TRIAL REGISTRATION: http://www.clinicaltrials.gov (NCT00716079).
Authors: Farhaan S Vahidy; Kaushik N Parsha; Mohammad H Rahbar; MinJae Lee; Thanh-Tung Bui; Claude Nguyen; Andrew D Barreto; Arvind B Bambhroliya; Preeti Sahota; Bing Yang; Jaroslaw Aronowski; Sean I Savitz Journal: J Cereb Blood Flow Metab Date: 2015-10-02 Impact factor: 6.200
Authors: Soo Young Kwon; Ahmed Z Obeidat; Padmini Sekar; Charles J Moomaw; Jennifer Osborne; Fernando D Testai; Sebastian Koch; Merredith R Lowe; Stacie Demel; Elisheva R Coleman; Matthew Flaherty; Daniel Woo Journal: Clin Neurol Neurosurg Date: 2020-02-07 Impact factor: 1.876
Authors: Candice Delcourt; Shoichiro Sato; Shihong Zhang; Else Charlotte Sandset; Danni Zheng; Xiaoying Chen; Maree L Hackett; Hisatomi Arima; Jun Hata; Emma Heeley; Rustam Al-Shahi Salman; Thompson Robinson; Leo Davies; Pablo M Lavados; Richard I Lindley; Christian Stapf; John Chalmers; Craig S Anderson Journal: Neurology Date: 2017-02-24 Impact factor: 9.910
Authors: Laura C Miyares; Guido J Falcone; Audrey Leasure; Opeolu Adeoye; Fu-Dong Shi; Steven J Kittner; Carl Langefeld; Achala Vagal; Kevin N Sheth; Daniel Woo Journal: Neurology Date: 2020-01-22 Impact factor: 9.910